Free CME from PeerView


Cardiology CME

Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
December 16, 2022
Credits: 1.0 CME
University of Florida College of Medicine
Personalizing the Management of Hyperlipidemia: Addressing Unmet Needs Among High-Risk Patients With Atherosclerotic Cardiovascular Disease With Novel Lipid-Lowering Therapies
November 07, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: Cardiology-Focused Perspectives on Using SGLT2 Inhibitors to Optimize Outcomes in Patients With Heart Failure
November 06, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Heart Failure Society of America
Pushing Back Against HCM: Can Cardiac Myosin Inhibitors Alter the Disease Progression and Management Trajectory for Patients With Hypertrophic Cardiomyopathy?
October 21, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?
September 29, 2022
Credits: 0.75 CME / MOC
University of Florida College of Medicine
New Therapies, New Hope: Evolving Strategies for Improving Outcomes and Quality of Life in Patients With Hypertrophic Cardiomyopathy
May 12, 2022
Credits: 1.0 CME / CPE
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
May 06, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
New Evidence on Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy: Analysis From Washington, DC
April 20, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
March 31, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
March 25, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
February 11, 2022
PVI, PeerView Institute for Medical Education
Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment
November 13, 2021
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
October 04, 2021
Medical Learning Institute, Inc.
A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
July 09, 2021
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
June 22, 2021
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
June 10, 2021

Pages